AVIR · Atea Pharmaceuticals, Inc. · Debt
$4.04
-0.01 (-0.25%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$322.82M
Shares
80.20M
Volume · Oct 23
245.44K
Avg daily vol (3M)
313.12K
Debt Profile
Completed filing coverage through Jul 23, 2021Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 424,000 | 10-Q filed 2026-08-12 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1593899
CUSIP
04683R106
13F (30d)
16 filings
16 filers
Visit website
Investor relations